<?release-delay 0|0 ?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties no_embargo?><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Acta Crystallogr Sect F Struct Biol Cryst Commun</journal-id><journal-id journal-id-type="publisher-id">Acta Cryst. F</journal-id><journal-title>Acta Crystallographica Section F: Structural Biology and Crystallization Communications</journal-title><issn pub-type="epub">1744-3091</issn><publisher><publisher-name>International Union of Crystallography</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">hc5048</article-id><article-id pub-id-type="doi">10.1107/S1744309108007136</article-id><article-id pub-id-type="coden">ACSFCL</article-id><article-id pub-id-type="pii">S1744309108007136</article-id><article-categories><subj-group subj-group-type="heading"><subject>Crystallization Communications</subject></subj-group></article-categories><title-group><article-title>Crystallization of hepatocyte nuclear factor 4&#x003b1; (HNF4&#x003b1;) in complex with the HNF1&#x003b1; promoter element</article-title><alt-title>Hepatocyte nuclear factor 4&#x003b1;</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lu</surname><given-names>Peng</given-names></name><xref ref-type="aff" rid="a">a</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Jianguo</given-names></name><xref ref-type="aff" rid="a">a</xref></contrib><contrib contrib-type="author"><name><surname>Melikishvili</surname><given-names>Manana</given-names></name><xref ref-type="aff" rid="a">a</xref></contrib><contrib contrib-type="author"><name><surname>Fried</surname><given-names>Michael G.</given-names></name><xref ref-type="aff" rid="a">a</xref></contrib><contrib contrib-type="author"><name><surname>Chi</surname><given-names>Young-In</given-names></name><xref ref-type="aff" rid="a">a</xref><xref ref-type="corresp" rid="cor">*</xref></contrib><aff id="a"><label>a</label>Department of Molecular and Cellular Biochemistry and Center for Structural Biology, University of Kentucky, Lexington, KY 40536, <country>USA</country></aff></contrib-group><author-notes><corresp id="cor">Correspondence e-mail: <email>ychi@uky.edu</email></corresp></author-notes><pub-date pub-type="collection"><day>1</day><month>4</month><year>2008</year></pub-date><pub-date pub-type="epub"><day>29</day><month>3</month><year>2008</year></pub-date><pub-date pub-type="pmc-release"><day>1</day><month>4</month><year>2008</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="collection"/>. --><volume>64</volume><issue>Pt 4</issue><issue-id pub-id-type="publisher-id">f080400</issue-id><fpage>313</fpage><lpage>317</lpage><history><date date-type="received"><day>29</day><month>1</month><year>2008</year></date><date date-type="accepted"><day>14</day><month>3</month><year>2008</year></date></history><permissions><copyright-statement>&#x000a9; International Union of Crystallography 2008</copyright-statement><copyright-year>2008</copyright-year><license license-type="open-access" xlink:href="http://journals.iucr.org/services/termsofuse.html"><p>This is an open-access article distributed under the terms described at http://journals.iucr.org/services/termsofuse.html.</p></license></permissions><self-uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1107/S1744309108007136">A full version of this article is available from Crystallography Journals Online.</self-uri><abstract abstract-type="toc"><p>Sample preparation, characterization, crystallization and preliminary X-ray analysis are reported for the HNF4&#x003b1;&#x02013;DNA binary complex.</p></abstract><abstract><p>Hepatocyte nuclear factor 4&#x003b1; (HNF4&#x003b1;) is a member of the nuclear receptor superfamily that plays a central role in organ development and metabolic functions. Mutations on <italic>HNF4&#x003b1;</italic> cause maturity-onset diabetes of the young (MODY), a dominant monogenic cause of diabetes. In order to understand the molecular mechanism of promoter recognition and the molecular basis of disease-causing mutations, the recombinant HNF4&#x003b1; DNA-binding domain was prepared and used in a study of its binding properties and in crystallization with a 21-mer DNA fragment that contains the promoter element of another MODY gene, <italic>HNF1&#x003b1;</italic>. The HNF4&#x003b1; protein displays a cooperative and specific DNA-binding activity towards its target gene-recognition elements. Crystals of the complex diffract to 2.0&#x02005;&#x000c5; using a synchrotron-radiation source under cryogenic (100&#x02005;K) conditions and belong to space group <italic>C</italic>2, with unit-cell parameters <italic>a</italic>&#x000a0;=&#x000a0;121.63, <italic>b</italic> = 35.43, <italic>c</italic> = 70.99&#x02005;&#x000c5;, &#x003b2; = 119.36&#x000b0;. A molecular-replacement solution has been obtained and structure refinement is in progress. This structure and the binding studies will provide the groundwork for detailed functional and biochemical studies of the MODY mutants.</p></abstract><kwd-group><kwd>protein&#x02013;DNA complex</kwd><kwd>gel-shift assay</kwd><kwd>diabetes</kwd><kwd>nuclear receptors</kwd><kwd>zinc-finger proteins</kwd></kwd-group></article-meta></front><body><sec sec-type="introduction" id="sec1"><label>1.</label><title>Introduction</title><p>Hepatocyte nuclear factor 4&#x003b1; (HNF4&#x003b1;) is a tissue-specific transcription factor that plays an essential role in early vertebrate development and embryonic survival. It regulates the expression of a wide variety of essential genes, including those involved in liver and pancreatic cell differentiation (Li <italic>et al.</italic>, 2000<xref ref-type="bibr" rid="bb14"> &#x025b6;</xref>; Odom <italic>et al.</italic>, 2004<xref ref-type="bibr" rid="bb19"> &#x025b6;</xref>), embryogenesis and early development (Duncan <italic>et al.</italic>, 1994<xref ref-type="bibr" rid="bb3"> &#x025b6;</xref>; Lausen <italic>et al.</italic>, 2000<xref ref-type="bibr" rid="bb13"> &#x025b6;</xref>), glucose metabolism (Stoffel &#x00026; Duncan, 1997<xref ref-type="bibr" rid="bb24"> &#x025b6;</xref>), lipid homeostasis (Hayhurst <italic>et al.</italic>, 2001<xref ref-type="bibr" rid="bb6"> &#x025b6;</xref>) and amino-acid metabolism (Schrem <italic>et al.</italic>, 2002<xref ref-type="bibr" rid="bb23"> &#x025b6;</xref>). Mutations in <italic>HNF4&#x003b1;</italic> cause a dominantly in&#x000ad;herited form of diabetes known as maturity-onset diabetes of the young (MODY; Yamagata <italic>et al.</italic>, 1996<xref ref-type="bibr" rid="bb30"> &#x025b6;</xref>). These mutations cause the loss of function of the gene product (Lausen <italic>et al.</italic>, 2000<xref ref-type="bibr" rid="bb13"> &#x025b6;</xref>), which leads to impaired insulin secretion and defects in metabolic pathways (Miura <italic>et al.</italic>, 2006<xref ref-type="bibr" rid="bb17"> &#x025b6;</xref>).</p><p>HNF4&#x003b1; is a prototypical member of a unique nuclear receptor superfamily (NR2A1; Nuclear Receptors Nomenclature Committee, 1999<xref ref-type="bibr" rid="bb18"> &#x025b6;</xref>) and exclusively functions as a homodimer (Jiang <italic>et al.</italic>, 1995<xref ref-type="bibr" rid="bb11"> &#x025b6;</xref>), despite its sequence homology to retinoic X receptor (RXR), which can readily heterodimerize with a related nuclear receptor (Szanto <italic>et al.</italic>, 2004<xref ref-type="bibr" rid="bb25"> &#x025b6;</xref>). HNF4&#x003b1; consists of distinctive functional domains including a DNA-binding domain (DBD), a ligand-binding domain (LBD) and additional domains with transcription-activation functions (AF; Schrem <italic>et al.</italic>, 2002<xref ref-type="bibr" rid="bb23"> &#x025b6;</xref>). However, the identity of its <italic>bona fide</italic> ligand is still under dispute (Hertz <italic>et al.</italic>, 1998<xref ref-type="bibr" rid="bb8"> &#x025b6;</xref>; Petrescu <italic>et al.</italic>, 2005<xref ref-type="bibr" rid="bb21"> &#x025b6;</xref>), even though its apparent ligand has been identified from structural studies (Dhe-Paganon <italic>et al.</italic>, 2002<xref ref-type="bibr" rid="bb2"> &#x025b6;</xref>; Wisely <italic>et al.</italic>, 2002<xref ref-type="bibr" rid="bb29"> &#x025b6;</xref>). HNF4&#x003b1;-DBD contains two zinc-finger motifs that specifically recognize and bind as a homodimer to a direct repeat of two hexameric half-sites separated by one (DR1; in the majority) or two nucleotides (DR2) (Jiang <italic>et al.</italic>, 1995<xref ref-type="bibr" rid="bb11"> &#x025b6;</xref>; Rajas <italic>et al.</italic>, 2002<xref ref-type="bibr" rid="bb22"> &#x025b6;</xref>). Five MODY1 missense mutations (on four different residues) are found within the region of our HNF4&#x003b1;-DBD construct (Fig. 1<xref ref-type="fig" rid="fig1"> &#x025b6;</xref><italic>a</italic>) and an additional MODY mutation is found in the HNF4&#x003b1;-binding site within the promoter of another MODY (MODY3) culprit gene <italic>HNF1&#x003b1;</italic> (Fig. 1<xref ref-type="fig" rid="fig1"> &#x025b6;</xref><italic>b</italic>; Gragnoli <italic>et al.</italic>, 1997<xref ref-type="bibr" rid="bb5"> &#x025b6;</xref>). Analysis of the structural consequences of each amino-acid substitution should be instructive as to the functional role of each residue. In order to elucidate the molecular basis of HNF4&#x003b1; function and the monogenic causes of diabetes, we have prepared and crystallized the human HNF4&#x003b1; DNA-binding domain in complex with a high-affinity HNF1&#x003b1; promoter element containing the HNF4&#x003b1; recognition sequence.</p></sec><sec sec-type="materials|methods" id="sec2"><label>2.</label><title>Materials and methods</title><sec id="sec2.1"><label>2.1.</label><title>Construction, expression and purification of HNF4&#x003b1; DNA-binding domain</title><p>The cDNA harboring the full-length human HNF-4&#x003b1;B splice variant (Kritis <italic>et al.</italic>, 1996<xref ref-type="bibr" rid="bb12"> &#x025b6;</xref>) was a kind gift from Dr Steve Shoelson of Joslin Diabetes Center. A fragment of human HNF4&#x003b1; cDNA (amino acids 46&#x02013;126) was subcloned by standard PCR into a pET41a vector (GE Healthcare). HNF4&#x003b1; was overexpressed in <italic>Escherichia coli</italic> BL21-Gold (Novagen) with induction by 0.5&#x02005;m<italic>M</italic> IPTG at an OD<sub>600</sub> of 0.8&#x02013;1.0 at 310&#x02005;K and harvested after culturing for an additional 3&#x02013;&#x000ad;4&#x02005;h. No zinc solution was added during the purification since there should be a sufficient amount of Zn atoms in the medium to be incorporated into the protein. The cells were lysed by sonication and the expressed GST-fusion proteins were isolated with the use of glutathione-agarose beads (Invitrogen) in bulk plus washing in the presence of 0.6&#x02005;<italic>M</italic> NaCl to prevent nonspecific binding to bacterial DNA. HNF4&#x003b1; was released by thrombin digestion from the resin after overnight incubation at 277&#x02005;K and was further purified by ion-exchange chromatography (Mono-S FPLC). Thrombin digestion produced a two-residue remnant (Gly-Ser) at the N-terminal end (Fig. 1<xref ref-type="fig" rid="fig1"> &#x025b6;</xref><italic>a</italic>). The purified protein was estimated to be at least 98% pure as judged by staining with Coomassie on 8&#x02013;25% gradient SDS&#x02013;PAGE gel (Fig. 2<xref ref-type="fig" rid="fig2"> &#x025b6;</xref>). Fractions were pooled and stored at 193&#x02005;K as a 10%(<italic>v</italic>/<italic>v</italic>) glycerol stock.</p></sec><sec id="sec2.2"><label>2.2.</label><title>Gel filtration of HNF4&#x003b1; DNA-binding domain</title><p>Gel filtration was performed on a Superdex 75 HR 10/30 column (GE Healthcare) equilibrated with running buffer containing 20&#x02005;m<italic>M</italic> Tris pH 7.5, 200&#x02005;m<italic>M</italic> NaCl, 1&#x02005;m<italic>M</italic> EDTA and 10&#x02005;m<italic>M</italic> 2-mercapto&#x000ad;ethanol. Elution was performed at a flow rate of 0.5&#x02005;ml&#x02005;min<sup>&#x02212;1</sup>. The apparent molecular weight of HNF4&#x003b1;-DBD was determined using the same column calibrated previously with a range of reference proteins (Bio-Rad): thyroglobulin (670&#x02005;kDa), bovine &#x003b3;-globulin (158&#x02005;kDa), chicken ovalbumin (44&#x02005;kDa), equine myoglobin (17&#x02005;kDa) and vitamin B<sub>12</sub> (1.4&#x02005;kDa). Blue dextran was used to determine the void volume of the column.</p></sec><sec id="sec2.3"><label>2.3.</label><title>Preparation of DNA oligomers</title><p>Tritylated oligonucleotides were purchased from the Midland Certified Reagent Company (Midland, Texas, USA) and further purified by reverse-phase HPLC on a C8 XTerra prep column (Waters) using a linear 5&#x02013;50%(<italic>v</italic>/<italic>v</italic>) acetonitrile gradient in 50&#x02005;m<italic>M</italic> triethylamine acetate buffer pH 7.0. Excess mobile phase containing acetonitrile was removed using HiTrapQ (GE Healthcare) and the trityl groups were removed with 80%(<italic>v</italic>/<italic>v</italic>) acetic acid. The deprotected oligonucleotides were precipitated with 75%(<italic>v</italic>/<italic>v</italic>) ethanol, dissolved in water for concentration measurement by <italic>A</italic><sub>260</sub> and lyophilized before storage at 193&#x02005;K. Double-stranded DNAs were generated for crystallization by heating equimolar amounts of complementary oligonucleotides to 358&#x02005;K for 10&#x02005;min and slowly cooling to 277&#x02005;K. The annealing buffer condition was 20&#x02005;m<italic>M</italic> Tris pH 8.0, 200&#x02005;m<italic>M</italic> NaCl and 1&#x02005;m<italic>M</italic> EDTA.</p></sec><sec id="sec2.4"><label>2.4.</label><title>Electrophoretic mobility-shift assay (EMSA)</title><p>Single-stranded oligonucleotides 1 and 2 (Fig. 1<xref ref-type="fig" rid="fig1"> &#x025b6;</xref><italic>b</italic>) were dissolved in 10&#x02005;m<italic>M</italic> Tris (pH 7.5 at 293&#x02005;K) and 1&#x02005;m<italic>M</italic> EDTA. Oligonucleotide 1 was 5&#x02032;-end labeled with <sup>32</sup>P as described by Maxam &#x00026; Gilbert (1977<xref ref-type="bibr" rid="bb16"> &#x025b6;</xref>). Labeled oligonucleotide 1 was mixed with a 1.1-fold molar excess of oligonucleotide 2 and the samples were heated to 363&#x02005;K and cooled slowly to 293&#x02005;K. DNA was transferred by dialysis into binding buffer [10&#x02005;m<italic>M</italic> Tris pH 8.0, 1&#x02005;m<italic>M</italic> EDTA, 100&#x02005;m<italic>M</italic> NaCl, 1&#x02005;m<italic>M</italic> MgCl<sub>2</sub>, 1&#x02005;m<italic>M</italic> DTT, 4%(<italic>v</italic>/<italic>v</italic>) glycerol]. DNA concentrations were measured by absorbance using a molar extinction coefficient &#x0220a;<sub>260</sub><sup>1cm</sup> of 2.57 &#x000d7; 10<sup>5</sup>. Samples were stored at 253&#x02005;K until use. EMSAs were carried out as described by Hellman &#x00026; Fried (2007<xref ref-type="bibr" rid="bb7"> &#x025b6;</xref>) using 10%(<italic>w</italic>/<italic>v</italic>) polyacrylamide gels cast and run in 45&#x02005;m<italic>M</italic> Tris&#x02013;borate, 2.5&#x02005;m<italic>M</italic> EDTA (pH 8.3 at 293&#x02005;K). Autoradiographic images were captured on storage phosphor screens (type GP, GE Healthcare), detected with a Typhoon phosphorimager and quantitated with <italic>Image-Quanta</italic> software (GE Healthcare). Data from serial dilution experiments were analyzed using the equations<disp-formula id="fd1"><graphic xlink:href="f-64-00313-efd1.jpg" mimetype="image" mime-subtype="gif" position="float"/></disp-formula>and <disp-formula id="fd2"><graphic xlink:href="f-64-00313-efd2.jpg" mimetype="image" mime-subtype="gif" position="float"/></disp-formula>Here, <italic>n</italic> is the binding stoichiometry, [<italic>P</italic><sub><italic>n</italic></sub><italic>D</italic>] and [<italic>D</italic>] the concentrations of complex and free DNA, respectively, and <italic>K</italic><sub>obs</sub> = [<italic>P</italic><sub><italic>n</italic></sub><italic>D</italic>]/[<italic>P</italic>]<sup><italic>n</italic></sup>[<italic>D</italic>]. When both <italic>n</italic> and <italic>K</italic><sub>obs</sub> are unknown (as in this case), iterative calculation of <italic>n</italic> and [<italic>P</italic>] using (1)<xref ref-type="disp-formula" rid="fd1"/> and (2)<xref ref-type="disp-formula" rid="fd2"/> results in convergence on self-consistent values of <italic>n</italic> and <italic>K</italic><sub>obs</sub> (Adams &#x00026; Fried, 2007<xref ref-type="bibr" rid="bb1"> &#x025b6;</xref>; Fried &#x00026; Crothers, 1984<xref ref-type="bibr" rid="bb4"> &#x025b6;</xref>).</p></sec><sec id="sec2.5"><label>2.5.</label><title>Dynamic light-scattering measurement</title><p>The effective molecular radius and the homogeneity/monodispersity of the complex within various particular buffer conditions were measured using the Solubility Screening Kit (Jena Biosciences) in conjunction with a Dynapro-99 dynamic light-scattering instrument (Proterion Corporation) and a DynaPro-MSTC200 microsampler (Protein Solutions). The results were analyzed using <italic>DYNAMICS</italic> v.5.26.60 (Protein Solutions). 20&#x02005;&#x000b5;l of sample was inserted into the cuvette with the temperature control set to 293&#x02005;K. The light-scattering signal was collected at a wavelength of 830.7&#x02005;nm. Protein concentrations were about 2&#x02005;mg&#x02005;ml<sup>&#x02212;1</sup> in each buffer and an average of 15 readings were recorded for each measurement.</p></sec><sec id="sec2.6"><label>2.6.</label><title>Crystallization and optimization</title><p>Protein&#x02013;DNA complexes were dialyzed in 20&#x02005;m<italic>M</italic> Tris pH 7.5, 75&#x02005;m<italic>M</italic> NaCl and 1&#x02005;m<italic>M</italic> DTT at 277&#x02005;K for 2.5&#x02005;h and concentrated to at least 10&#x02005;mg&#x02005;ml<sup>&#x02212;1</sup>. The initial crystallization trials were carried out at 295&#x02005;K in 24-well plates using the hanging-drop vapor-diffusion method with a sparse-matrix screen (Jancarik &#x00026; Kim, 1991<xref ref-type="bibr" rid="bb9"> &#x025b6;</xref>) and similar commercially available versions such as Crystal Screens I and II (Hampton Research), Natrix and PEG/Ion Screens (Hampton Research), Cryo I and II (Molecular Dimensions) and Wizard I and II (deCODE Genetics).</p><p>Drops consisting of 0.5&#x02005;&#x000b5;l protein&#x02013;DNA solution were mixed with an equal volume of reservoir solution and equilibrated against 500&#x02005;&#x000b5;l reservoir solution. Although many different DNA constructs varying in length and the nature of the ending (blunt end <italic>versus</italic> overhang) were screened, diffraction-quality crystals were only reproducibly obtained using the overhang 21-mer shown in Fig. 1<xref ref-type="fig" rid="fig1"> &#x025b6;</xref>(<italic>b</italic>) (the two HNF4&#x003b1; direct-repeat recognition sites are indicated by the boxes). Conditions yielding small crystals were further optimized by variation of the crystallization parameters and additives. The final condition, which produced somewhat flat bipyramidal crystals at 295&#x02005;K, contained 26%(<italic>v</italic>/<italic>v</italic>) PEG 4000, 80&#x02005;m<italic>M</italic> magnesium acetate and 50&#x02005;m<italic>M</italic> sodium citrate pH 4.8.</p></sec><sec id="sec2.7"><label>2.7.</label><title>Data collection and processing</title><p>The crystals were transferred into mother liquor containing an additional 15%(<italic>v</italic>/<italic>v</italic>) glycerol as a cryoprotectant before being directly plunged into liquid nitrogen and stored for data collection. The native data were collected at 100&#x02005;K at APS (SER-CAT 22BM) using a MAR 225 CCD detector and an oscillation angle of 1&#x000b0; with 2&#x02005;s exposure and were processed using <italic>HKL</italic>-2000 (Otwinowski &#x00026; Minor, 1997<xref ref-type="bibr" rid="bb20"> &#x025b6;</xref>). The wavelength used was 0.92017&#x02005;&#x000c5;.</p></sec></sec><sec sec-type="discussion|interpretation" id="sec3"><label>3.</label><title>Results and discussion</title><p>Recombinant HNF4&#x003b1;-DBD (amino acids 46&#x02013;126; Fig. 1<xref ref-type="fig" rid="fig1"> &#x025b6;</xref><italic>a</italic>) was purified to homogeneity and mixed with pure DNA for subsequent studies. Gel-filtration experiments showed that the HNF4&#x003b1;-DBD protein existed as a monomer in solution (Fig. 2<xref ref-type="fig" rid="fig2"> &#x025b6;</xref>). Purified HNF4&#x003b1;-DBD protein forms a single complex with DNA containing its target sequence (Figs. 3<xref ref-type="fig" rid="fig3"> &#x025b6;</xref><italic>a</italic> and 3<xref ref-type="fig" rid="fig3"> &#x025b6;</xref><italic>b</italic>). Serial dilution analysis (Figs. 3<xref ref-type="fig" rid="fig3"> &#x025b6;</xref><italic>b</italic> and 3<xref ref-type="fig" rid="fig3"> &#x025b6;</xref><italic>c</italic>) revealed that the stoichiometry of the complex was 2:1 HNF4&#x003b1;:dsDNA, with an association constant <italic>K</italic><sub>obs</sub> of 8.48 &#x000b1; 0.67 &#x000d7; 10<sup>10</sup>&#x02005; <italic>M</italic><sup>&#x02212;2</sup>. The corresponding monomer equivalent dissociation constant was 3.43 &#x000b1; 0.13 &#x000d7; 10<sup>&#x02212;6</sup>&#x02005; <italic>M</italic>. The formation of a 2:1 complex without the accumulation of detectable levels of the 1:1 intermediate indicates that binding is cooperative. These features will serve as a reference when we study the effects of MODY mutations on DNA binding in the near future.</p><p>Dynamic light scattering (DLS) is a useful tool to monitor protein solubility behavior and to predict favorable crystallization conditions (Wilson, 2003<xref ref-type="bibr" rid="bb27"> &#x025b6;</xref>). We used the Solubility Screening Kit (Jena Biosiences) in conjunction with DLS (Jancarik <italic>et al.</italic>, 2004<xref ref-type="bibr" rid="bb10"> &#x025b6;</xref>) in order to identify the optimal buffer conditions for complex formation and crystallization. The best polydispersity value of 0.06 was obtained with a buffer containing 20&#x02005;m<italic>M</italic> Tris pH 7.5 and 75&#x02005;m<italic>M</italic> NaCl and this optimal buffer was used for subsequent crystallization.</p><p>For crystallization, purified HNF4&#x003b1; 46&#x02013;126 and various DNAs were simply mixed in a 2:1.2 molar ratio, dialyzed against the optimal binding buffer (20&#x02005;m<italic>M</italic> Tris pH 7.5, 75&#x02005;m<italic>M</italic> NaCl) and concentrated using 10&#x02005;kDa molecular-weight cutoff concentrators (Millipore). The protein&#x02013;DNA concentration was 10&#x02005;mg&#x02005;ml<sup>&#x02212;1</sup> for initial screenings and 20&#x02005;mg&#x02005;ml<sup>&#x02212;1</sup> for final optimization. Crystals with the overhang 21-&#x000ad;mer DNA (Fig.&#x000a0;1<xref ref-type="fig" rid="fig1"> &#x025b6;</xref><italic>b</italic>) were grown at 295&#x02005;K using the hanging-drop vapor-diffusion method and the presence of the HNF4&#x003b1;&#x02013;DNA complex in the crystals was confirmed by running SDS&#x02013;PAGE and 0.5%(<italic>w</italic>/<italic>v</italic>) agarose gels (data not shown). Crystals initially appeared within 2&#x02005;d and continued to grow until they reached average dimensions of 0.05 &#x000d7; 0.1 &#x000d7; 0.2&#x02005;mm (Fig. 4<xref ref-type="fig" rid="fig4"> &#x025b6;</xref>). A range of solution conditions varying the pH, temperature and concentrations of additives such as organic solvents, divalent cations and polyamines were used to attempt to improve the crystal quality. The final optimized condition contains 26%(<italic>v</italic>/<italic>v</italic>) PEG 4000, 80&#x02005;m<italic>M</italic> magnesium acetate and 50&#x02005;m<italic>M</italic> sodium citrate pH 4.8. The best crystal diffracted to 2.0&#x02005;&#x000c5; at the synchrotron source and belongs to space group <italic>C</italic>2, with unit-cell parameters <italic>a</italic> = 121.63, <italic>b</italic>&#x000a0;=&#x000a0;35.43, <italic>c</italic> = 70.99&#x02005;&#x000c5;, &#x003b2; = 119.36&#x000b0; (Fig. 5<xref ref-type="fig" rid="fig5"> &#x025b6;</xref>). The value of the Matthews coefficient (Matthews, 1968<xref ref-type="bibr" rid="bb15"> &#x025b6;</xref>) is 2.12&#x02005;&#x000c5;<sup>3</sup>&#x02005;Da<sup>&#x02212;1</sup> for one complex (two HNF4&#x003b1; and one dsDNA) in the asymmetric unit and the estimated solvent content is 41.6% based on a protein specific density of 1.34. Final native data-collection statistics are summarized in Table 1<xref ref-type="table" rid="table1"> &#x025b6;</xref>.</p><p>The structure was determined by molecular replacement using the RXR&#x02013;RAR&#x02013;DNA complex structure (PDB code <ext-link ext-link-type="uri" xlink:href="http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=1dsz">1dsz</ext-link>) as a search model and the program <italic>MOLREP</italic> (Vagin &#x00026; Teplyakov, 1997<xref ref-type="bibr" rid="bb26"> &#x025b6;</xref>) from the <italic>CCP</italic>4 suite (Winn, 2003<xref ref-type="bibr" rid="bb28"> &#x025b6;</xref>). An unambiguous solution was found that gave an initial <italic>R</italic> value of 51.4% and a correlation coefficient of 0.38 using data in the resolution range 15&#x02013;3.0&#x02005;&#x000c5;. The subsequent &#x003c3;<sub>A</sub>-weighted 2<italic>F</italic><sub>o</sub> &#x02212; <italic>F</italic><sub>c</sub> map after rigid-body refinement clearly revealed density corresponding to the structural differences between the search model and the HNF4&#x003b1;&#x02013;DNA complex. Model improvement and refinement of the structure are in progress.</p></sec></body><back><ack><p>We wish to thank the staff at Advanced Photon Source beamline 22-BM (SER-CAT) for their help with data collection and David Rodgers for the use of the tissue-culture and protein-production core facility. Use of the Advanced Photon Source is supported by the US Department of Energy. This work was funded by a Juvenile Diabetes Research Foundation grant (2004-503) and NIH Grant P20RR20171 from the COBRE program of the National Center for Research Resources to YIC and NIH grant GM070662 to MGF.</p></ack><ref-list><title>References</title><ref id="bb1"><citation citation-type="other">Adams, C. &#x00026; Fried, M. G. (2007). <italic>Protein Interactions: Biophysical Approaches for the Study of Multicomponent Systems</italic>, edited by P. Schuck, pp. 417&#x02013;446. New York: Academic Press.</citation></ref><ref id="bb2"><citation citation-type="other">Dhe-Paganon, S., Duda, K., Iwamoto, M., Chi, Y. I. &#x00026; Shoelson, S. E. (2002). <italic>J. Biol. Chem.</italic><bold>277</bold>, 37973&#x02013;37976.</citation></ref><ref id="bb3"><citation citation-type="other">Duncan, S. A., Manova, K., Chen, W. S., Hoodless, P., Weinstein, D. C., Bachvarova, R. F. &#x00026; Darnell, J. E. Jr (1994). <italic>Proc. Natl Acad. Sci. USA</italic>, <bold>91</bold>, 7598&#x02013;7602.</citation></ref><ref id="bb4"><citation citation-type="other">Fried, M. G. &#x00026; Crothers, D. M. (1984). <italic>J. Mol. Biol.</italic><bold>172</bold>, 241&#x02013;262.</citation></ref><ref id="bb5"><citation citation-type="other">Gragnoli, C., Lindner, T., Cockburn, B. N., Kaisaki, P. J., Gragnoli, F., Marozzi, G. &#x00026; Bell, G. I. (1997). <italic>Diabetes</italic>, <bold>46</bold>, 1648&#x02013;1651.</citation></ref><ref id="bb6"><citation citation-type="other">Hayhurst, G. P., Lee, Y. H., Lambert, G., Ward, J. M. &#x00026; Gonzalez, F. J. (2001). <italic>Mol. Cell. Biol.</italic><bold>21</bold>, 1393&#x02013;1403.</citation></ref><ref id="bb7"><citation citation-type="other">Hellman, L. M. &#x00026; Fried, M. G. (2007). <italic>Nature Protocols</italic>, <bold>2</bold>, 1849&#x02013;1861.</citation></ref><ref id="bb8"><citation citation-type="other">Hertz, R., Magenheim, J., Berman, I. &#x00026; Bar-Tana, J. (1998). <italic>Nature (London)</italic>, <bold>392</bold>, 512&#x02013;516.</citation></ref><ref id="bb9"><citation citation-type="other">Jancarik, J. &#x00026; Kim, S.-H. (1991). <italic>J. Appl. Cryst.</italic><bold>24</bold>, 409&#x02013;411.</citation></ref><ref id="bb10"><citation citation-type="other">Jancarik, J., Pufan, R., Hong, C., Kim, S.-H. &#x00026; Kim, R. (2004). <italic>Acta Cryst.</italic> D<bold>60</bold>, 1670&#x02013;1673.</citation></ref><ref id="bb11"><citation citation-type="other">Jiang, G., Nepomuceno, L., Hopkins, K. &#x00026; Sladek, F. M. (1995). <italic>Mol. Cell. Biol.</italic><bold>15</bold>, 5131&#x02013;5143.</citation></ref><ref id="bb12"><citation citation-type="other">Kritis, A. A., Argyrokastritis, A., Moschonas, N. K., Power, S., Katrakili, N., Zannis, V. I., Cereghini, S. &#x00026; Talianidis, I. (1996). <italic>Gene</italic>, <bold>173</bold>, 275&#x02013;280.</citation></ref><ref id="bb13"><citation citation-type="other">Lausen, J., Thomas, H., Lemm, I., Bulman, M., Borgschulze, M., Lingott, A., Hattersley, A. T. &#x00026; Ryffel, G. U. (2000). <italic>Nucleic Acids Res.</italic><bold>28</bold>, 430&#x02013;437.</citation></ref><ref id="bb14"><citation citation-type="other">Li, J., Ning, G. &#x00026; Duncan, S. A. (2000). <italic>Genes Dev.</italic><bold>14</bold>, 464&#x02013;474.</citation></ref><ref id="bb15"><citation citation-type="other">Matthews, B. W. (1968). <italic>J. Mol. Biol.</italic><bold>33</bold>, 491&#x02013;497.</citation></ref><ref id="bb16"><citation citation-type="other">Maxam, A. M. &#x00026; Gilbert, W. (1977). <italic>Proc. Natl Acad. Sci. USA</italic>, <bold>74</bold>, 560&#x02013;564.</citation></ref><ref id="bb17"><citation citation-type="other">Miura, A., Yamagata, K., Kakei, M., Hatakeyama, H., Takahashi, N., Fukui, K., Nammo, T., Yoneda, K., Inoue, Y., Sladek, F. M., Magnuson, M. A., Kasai, H., Miyagawa, J., Gonzalez, F. J. &#x00026; Shimomura, I. (2006). <italic>J. Biol. Chem.</italic><bold>281</bold>, 5246&#x02013;5257.</citation></ref><ref id="bb18"><citation citation-type="other">Nuclear Receptors Nomenclature Committee (1999). <italic>Cell</italic>, <bold>97</bold>, 161&#x02013;163.</citation></ref><ref id="bb19"><citation citation-type="other">Odom, D. T., Zizlsperger, N., Gordon, D. B., Bell, G. W., Rinaldi, N. J., Murray, H. L., Volkert, T. L., Schreiber, J., Rolfe, P. A., Gifford, D. K., Fraenkel, E., Bell, G. I. &#x00026; Young, R. A. (2004). <italic>Science</italic>, <bold>303</bold>, 1378&#x02013;1381.</citation></ref><ref id="bb20"><citation citation-type="other">Otwinowski, Z. &#x00026; Minor, W. (1997). <italic>Methods Enzymol.</italic><bold>276</bold>, 307&#x02013;326.</citation></ref><ref id="bb21"><citation citation-type="other">Petrescu, A. D., Hertz, R., Bar-Tana, J., Schroeder, F. &#x00026; Kier, A. B. (2005). <italic>J. Biol. Chem.</italic><bold>280</bold>, 16714&#x02013;16727.</citation></ref><ref id="bb22"><citation citation-type="other">Rajas, F., Gautier, A., Bady, I., Montano, S. &#x00026; Mithieux, G. (2002). <italic>J. Biol. Chem.</italic><bold>277</bold>, 15736&#x02013;15744.</citation></ref><ref id="bb23"><citation citation-type="other">Schrem, H., Klempnauer, J. &#x00026; Borlak, J. (2002). <italic>Pharmacol. Rev.</italic><bold>54</bold>, 129&#x02013;158.</citation></ref><ref id="bb24"><citation citation-type="other">Stoffel, M. &#x00026; Duncan, S. A. (1997). <italic>Proc. Natl Acad. Sci. USA</italic>, <bold>94</bold>, 13209&#x02013;13214.</citation></ref><ref id="bb25"><citation citation-type="other">Szanto, A., Narkar, V., Shen, Q., Uray, I. P., Davies, P. J. &#x00026; Nagy, L. (2004). <italic>Cell Death Differ.</italic><bold>11</bold>, <italic>Suppl.</italic> 2, S126&#x02013;S143.</citation></ref><ref id="bb26"><citation citation-type="other">Vagin, A. &#x00026; Teplyakov, A. (1997). <italic>J. Appl. Cryst.</italic><bold>30</bold>, 1022&#x02013;1025.</citation></ref><ref id="bb27"><citation citation-type="other">Wilson, W. W. (2003). <italic>J. Struct. Biol.</italic><bold>142</bold>, 56&#x02013;65.</citation></ref><ref id="bb28"><citation citation-type="other">Winn, M. D. (2003). <italic>J. Synchrotron Rad.</italic><bold>10</bold>, 23&#x02013;25.</citation></ref><ref id="bb29"><citation citation-type="other">Wisely, G. B., Miller, A. B., Davis, R. G., Thornquest, A. D. Jr, Johnson, R., Spitzer, T., Sefler, A., Shearer, B., Moore, J. T., Willson, T. M. &#x00026; Williams, S. P. (2002). <italic>Structure</italic>, <bold>10</bold>, 1225&#x02013;1234.</citation></ref><ref id="bb30"><citation citation-type="other">Yamagata, K., Furuta, H., Oda, N., Kaisaki, P. J., Menzel, S., Cox, N. J., Fajans, S. S., Signorini, S., Stoffel, M. &#x00026; Bell, G. I. (1996). <italic>Nature (London)</italic>, <bold>384</bold>, 458&#x02013;460.</citation></ref></ref-list></back><floats-wrap><fig id="fig1" position="float"><label>Figure 1</label><caption><p>The protein and DNA constructs used in characterization and crystallization. (<italic>a</italic>) Human HNF4&#x003b1;-DBD protein sequence. The predicted DNA-recognition helix is boxed and the MODY mutations are shown in red. Cloning artifacts from the expression vector are indicated by lower case letters at the N-terminal end. (<italic>b</italic>) The natural HNF1&#x003b1; promoter sequence (&#x02212;46 to &#x02212;66; Gragnoli <italic>et al.</italic>, 1997<xref ref-type="bibr" rid="bb5"> &#x025b6;</xref>) containing the HNF4&#x003b1; recognition site used in crystallization and binding studies. Two direct-repeat half-sites are boxed and the MODY mutation is shown in red.</p></caption><graphic xlink:href="f-64-00313-fig1"/></fig><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Gel filtration of HNF4&#x003b1;-DBD with the molecular-weight standard samples (labelled in kDa). HNF4&#x003b1;-DBD is homogeneous and appears to be a monomer in solution. The SDS&#x02013;PAGE of purified HNF4&#x003b1;-DBD along with the molecular-weight standard is shown in the inset.</p></caption><graphic xlink:href="f-64-00313-fig2"/></fig><fig id="fig3" position="float"><label>Figure 3</label><caption><p>Binding of HNF4&#x003b1;-DBD to duplex 21-mer target DNA detected by EMSA. Reactions were carried out in 10&#x02005;m<italic>M</italic> Tris (pH 8.0&#x02005;at 293&#x02005;K), 1&#x02005;m<italic>M</italic> EDTA, 100&#x02005;m<italic>M</italic> NaCl, 1&#x02005;m<italic>M</italic> MgCl<sub>2</sub>, 1&#x02005;m<italic>M</italic> DTT, 4% glycerol, 100&#x02005;&#x000b5;g&#x02005;ml<sup>&#x02212;1</sup> BSA. (<italic>a</italic>) Forward titration. All samples contained 0.21&#x02005;&#x000b5;<italic>M</italic> duplex 21-mer. Samples contained HNF4&#x003b1;-DBD protein, from the second lane, at 0.41, 0.82, 1.23, 2.05, 2.87, 3.69, 4.51, 5.33, 6.56, 8.2, 12.0 and 20.5&#x02005;&#x000b5;<italic>M</italic>, respectively. (<italic>b</italic>) Serial dilution. The first lane contained reference DNA; the initial sample (second lane) contained 0.2&#x02005;&#x000b5;<italic>M</italic> duplex 21-mer and 17.9&#x02005;&#x000b5;<italic>M</italic> HNF4&#x003b1;-DBD protein. Each succeeding lane contained an aliquot of the previous sample diluted 1.2-fold. (<italic>c</italic>) Determination of stoichiometry and association constant. Graph of ln[<italic>P</italic><sub><italic>n</italic></sub><italic>D</italic>]/[<italic>D</italic>] as a function of ln[<italic>P</italic>]. The slope about the mid-point of the reaction (where ln[<italic>P</italic><sub><italic>n</italic></sub><italic>D</italic>]/[<italic>D</italic>] = 0) gives the stoichiometry (<italic>n</italic> = 2.3 &#x000b1; 0.2). The data used for this determination are indicated by filled circles. The data near binding saturation (filled squares) deviate from the linear relationship and were excluded from the fit. A fit of (1)<xref ref-type="disp-formula" rid="fd1"/> to the linear data returned an intercept value of ln[<italic>P</italic>] = &#x02212;12.58 &#x000b1; 0.03, equivalent to <italic>K</italic><sub>obs</sub> = 8.48 &#x000b1; 0.67 &#x000d7; 10<sup>10</sup>&#x02005; <italic>M</italic><sup>&#x02212;2</sup>.</p></caption><graphic xlink:href="f-64-00313-fig3"/></fig><fig id="fig4" position="float"><label>Figure 4</label><caption><p>Typical crystals of the HNF4&#x003b1;&#x02013;DNA complex.</p></caption><graphic xlink:href="f-64-00313-fig4"/></fig><fig id="fig5" position="float"><label>Figure 5</label><caption><p>A typical X-ray diffraction pattern from a crystal of the HNF4&#x003b1;&#x02013;DNA complex. A small section near the water ring is enlarged and shown in the inset. The overall mosaicity of the crystal was 0.3&#x000b0;.</p></caption><graphic xlink:href="f-64-00313-fig5"/></fig><table-wrap id="table1" position="float"><label>Table 1</label><caption><title>Data-collection statistics for the HNF4&#x003b1;&#x02013;DNA crystal</title><p>Values in parentheses are for the highest resolution bin.</p></caption><table frame="hsides" rules="groups"><tbody valign="top"><tr><td rowspan="1" colspan="1" align="left" valign="top">Space group</td><td rowspan="1" colspan="1" align="left" valign="top"><italic>C</italic>2</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Unit-cell parameters (&#x000c5;, &#x000b0;)</td><td rowspan="1" colspan="1" align="left" valign="top"><italic>a</italic> = 121.63, <italic>b</italic> = 35.43, <italic>c</italic> = 70.99, &#x003b2; = 119.36</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Resolution (&#x000c5;)</td><td rowspan="1" colspan="1" align="left" valign="top">30.29&#x02013;2.00 (2.07&#x02013;2.00)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Observed reflections</td><td rowspan="1" colspan="1" align="left" valign="top">94972</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Unique reflections</td><td rowspan="1" colspan="1" align="left" valign="top">17094</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Redundancy</td><td rowspan="1" colspan="1" align="left" valign="top">5.6 (3.6)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Completeness (%)</td><td rowspan="1" colspan="1" align="left" valign="top">93.9 (72.4)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top"><italic>I</italic>/&#x003c3;(<italic>I</italic>)</td><td rowspan="1" colspan="1" align="left" valign="top">12.1 (4.5)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top"><italic>R</italic><sub>merge</sub><xref ref-type="table-fn" rid="tfn1">&#x02020;</xref> (%)</td><td rowspan="1" colspan="1" align="left" valign="top">6.4 (30.4)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Matthews coefficient (&#x000c5;<sup>3</sup>&#x02005;Da<sup>&#x02212;1</sup>)</td><td rowspan="1" colspan="1" align="left" valign="top">2.12</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Solvent content (%)</td><td rowspan="1" colspan="1" align="left" valign="top">41.61</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Molecules per ASU</td><td rowspan="1" colspan="1" align="left" valign="top">One complex (2&#x02005;HNF4&#x003b1;, 1&#x02005;dsDNA)</td></tr></tbody></table><table-wrap-foot><fn id="tfn1"><label>&#x02020;</label><p><italic>R</italic><sub>merge</sub> = <inline-formula><inline-graphic xlink:href="f-64-00313-efi1.jpg" mimetype="image" mime-subtype="gif"/></inline-formula><inline-formula><inline-graphic xlink:href="f-64-00313-efi2.jpg" mimetype="image" mime-subtype="gif"/></inline-formula>, where <italic>I<sub>i</sub></italic>(<italic>hkl</italic>) is the intensity of reflection <italic>hkl</italic>, <inline-formula><inline-graphic xlink:href="f-64-00313-efi3.jpg" mimetype="image" mime-subtype="gif"/></inline-formula> is the sum over all reflections and <inline-formula><inline-graphic xlink:href="f-64-00313-efi4.jpg" mimetype="image" mime-subtype="gif"/></inline-formula> is the sum over <italic>i</italic> measurements of reflection <italic>h</italic>.</p></fn></table-wrap-foot></table-wrap></floats-wrap></article> 